Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.

MLA

Hompland, Ivar, et al. “Outcome in Dedifferentiated Chondrosarcoma for Patients Treated with Multimodal Therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.” European Journal of Cancer (Oxford, England : 1990), vol. 151, July 2021, pp. 150–58. EBSCOhost, https://doi.org/10.1016/j.ejca.2021.04.017.

APA

Hompland, I., Ferrari, S., Bielack, S., Palmerini, E., Hall, K. S., Picci, P., Hecker-Nolting, S., Donati, D. M., Blattmann, C., Bjerkehagen, B., Staals, E., Kager, L., Gambarotti, M., Kühne, T., Eriksson, M., Ferraresi, V., Kevric, M., Biagini, R., Baumhoer, D., … Smeland, S. (2021). Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study. European Journal of Cancer (Oxford, England : 1990), 151, 150–158. https://doi.org/10.1016/j.ejca.2021.04.017

Chicago

Hompland, Ivar, Stefano Ferrari, Stefan Bielack, Emanuela Palmerini, Kirsten S Hall, Pierro Picci, Stefanie Hecker-Nolting, et al. 2021. “Outcome in Dedifferentiated Chondrosarcoma for Patients Treated with Multimodal Therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.” European Journal of Cancer (Oxford, England : 1990) 151 (July): 150–58. doi:10.1016/j.ejca.2021.04.017.